Collegeville, PA, United States of America

Maben Ying

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maben Ying. Retrieved from https://idiyas.com/inventor/maben-ying

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maben Ying - Innovator in Pharmaceutical Development

Introduction

Maben Ying is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for therapeutic use.

Latest Patents

Maben Ying holds 1 patent for his invention related to MrgX2 antagonists. This invention pertains to novel compounds according to Formula (I), which serve as antagonists of MrgX2. The patent also covers pharmaceutical compositions containing these compounds and their application in treating MrgX2-mediated diseases and disorders.

Career Highlights

Maben Ying is associated with GlaxoSmithKline Intellectual Property Development Limited, where he has been instrumental in advancing pharmaceutical innovations. His work focuses on developing new therapeutic options that can improve patient outcomes.

Collaborations

Maben has collaborated with notable colleagues, including Rodolfo Cadilla and Barry George Shearer, contributing to a dynamic research environment that fosters innovation.

Conclusion

Maben Ying's contributions to pharmaceutical development highlight his role as an inventor dedicated to improving healthcare through innovative solutions. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…